- International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome2018 | First Faculty of Medicine
- International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)2017 | First Faculty of Medicine
- The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders2016 | First Faculty of Medicine
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia2015 | Second Faculty of Medicine
- Diabetic foot syndrome - prevention, diagnosis and therapy: Adapted recommended procedure based on international guidelines2022 | Central Library of Charles University
- Physiological distribution and interpretation of levels of blood pressure in childhood and adolescence2001 | Third Faculty of Medicine
- A high-throughput pipeline for validation of antibodies2018 | Second Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | First Faculty of Medicine
- Treatment of anaemia with erythropoiesis-stimulating proteins in patients with myelodysplastic syndrome2010 | Publication without faculty affiliation
- Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies2020 | First Faculty of Medicine
- CBOL Protist Working Group: Barcoding Eukaryotic Richness beyond the Animal, Plant, and Fungal Kingdoms2012 | Faculty of Science
- Long term survivors of childhood cancer: Cure and care. The ERICE statement2009 | Second Faculty of Medicine
- Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment2018 | First Faculty of Medicine
- Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines2021 | First Faculty of Medicine
- Defining the critical hurdles in cancer immunotherapy2011 | Second Faculty of Medicine
- Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry2021 | First Faculty of Medicine
- A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy2018 | First Faculty of Medicine
- International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study2021 | First Faculty of Medicine
- Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia2022 | First Faculty of Medicine
- Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové